Correlation Between Biomerieux and Neovacs SA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biomerieux and Neovacs SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomerieux and Neovacs SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomerieux SA and Neovacs SA, you can compare the effects of market volatilities on Biomerieux and Neovacs SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomerieux with a short position of Neovacs SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomerieux and Neovacs SA.

Diversification Opportunities for Biomerieux and Neovacs SA

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Biomerieux and Neovacs is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Biomerieux SA and Neovacs SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neovacs SA and Biomerieux is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomerieux SA are associated (or correlated) with Neovacs SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neovacs SA has no effect on the direction of Biomerieux i.e., Biomerieux and Neovacs SA go up and down completely randomly.

Pair Corralation between Biomerieux and Neovacs SA

Assuming the 90 days trading horizon Biomerieux SA is expected to generate 0.06 times more return on investment than Neovacs SA. However, Biomerieux SA is 16.04 times less risky than Neovacs SA. It trades about 0.03 of its potential returns per unit of risk. Neovacs SA is currently generating about -0.12 per unit of risk. If you would invest  9,549  in Biomerieux SA on August 30, 2024 and sell it today you would earn a total of  356.00  from holding Biomerieux SA or generate 3.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Biomerieux SA  vs.  Neovacs SA

 Performance 
       Timeline  
Biomerieux SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biomerieux SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong primary indicators, Biomerieux is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Neovacs SA 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Neovacs SA are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Neovacs SA reported solid returns over the last few months and may actually be approaching a breakup point.

Biomerieux and Neovacs SA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biomerieux and Neovacs SA

The main advantage of trading using opposite Biomerieux and Neovacs SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomerieux position performs unexpectedly, Neovacs SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neovacs SA will offset losses from the drop in Neovacs SA's long position.
The idea behind Biomerieux SA and Neovacs SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Commodity Directory
Find actively traded commodities issued by global exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments